ARCHIVES

FASEB urges 10 percent increase for NIH in FY 2005.

This article is from The Cancer Letter archive.

Vol. 30 No. 04 | January 23, 2004

Download PDF Visit The Full Archive

Related Articles

ACS Cancer Control Research Grant Programs Available

May 5, 2000

Healthcare Utilization Figures More Than Biology In Disparity

April 30, 2010

In Brief: Money Bill Delay Seen Until After Election ACCC Meeting Planned On Community Programs

September 15, 1978

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997

US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.

July 28, 2000

FDA Designates Zometa For Priority Review.

November 30, 2001